Ng, Kiu Yan Charlotte
 Distribuzione geografica
Continente #
NA - Nord America 4.230
AS - Asia 3.099
SA - Sud America 617
EU - Europa 534
Continente sconosciuto - Info sul continente non disponibili 170
AF - Africa 74
OC - Oceania 9
Totale 8.733
Nazione #
US - Stati Uniti d'America 4.059
SG - Singapore 1.806
CN - Cina 620
BR - Brasile 504
VN - Vietnam 258
IT - Italia 204
HK - Hong Kong 156
CA - Canada 79
GB - Regno Unito 73
DE - Germania 54
IN - India 49
MX - Messico 42
BD - Bangladesh 41
FR - Francia 39
AR - Argentina 36
RU - Federazione Russa 29
TR - Turchia 24
VE - Venezuela 23
ZA - Sudafrica 23
EC - Ecuador 21
PL - Polonia 20
IQ - Iraq 19
FI - Finlandia 16
NL - Olanda 16
MY - Malesia 14
PK - Pakistan 14
UZ - Uzbekistan 14
CR - Costa Rica 12
IE - Irlanda 12
JP - Giappone 12
SA - Arabia Saudita 12
PH - Filippine 11
CL - Cile 10
ES - Italia 10
KE - Kenya 10
UA - Ucraina 9
HN - Honduras 8
MA - Marocco 8
SE - Svezia 8
CO - Colombia 7
CZ - Repubblica Ceca 7
GT - Guatemala 7
ID - Indonesia 7
NG - Nigeria 7
AU - Australia 6
DZ - Algeria 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
JM - Giamaica 5
LB - Libano 5
LV - Lettonia 5
NI - Nicaragua 5
AM - Armenia 4
AZ - Azerbaigian 4
BO - Bolivia 4
NP - Nepal 4
TN - Tunisia 4
BE - Belgio 3
EE - Estonia 3
EG - Egitto 3
ET - Etiopia 3
GR - Grecia 3
IL - Israele 3
KG - Kirghizistan 3
LT - Lituania 3
LU - Lussemburgo 3
PR - Porto Rico 3
RO - Romania 3
SN - Senegal 3
SV - El Salvador 3
AL - Albania 2
BG - Bulgaria 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GY - Guiana 2
JO - Giordania 2
MG - Madagascar 2
NZ - Nuova Zelanda 2
PE - Perù 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AO - Angola 1
AT - Austria 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BT - Bhutan 1
BY - Bielorussia 1
CD - Congo 1
CH - Svizzera 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 8.555
Città #
Singapore 747
San Jose 681
Ashburn 457
The Dalles 291
New York 281
Shanghai 248
Dallas 183
Council Bluffs 177
Beijing 174
Santa Clara 153
Hong Kong 152
Los Angeles 129
Ho Chi Minh City 95
Milan 78
Buffalo 60
Hanoi 57
São Paulo 45
Boardman 37
Phoenix 35
Wilmington 31
Chicago 26
Brooklyn 23
Orem 21
Rome 21
San Mateo 21
North Bergen 20
Atlanta 19
Toronto 19
Chennai 18
Johannesburg 18
Mexico City 18
Warsaw 17
Munich 16
Seattle 16
Da Nang 15
Denver 15
Frankfurt am Main 15
Rio de Janeiro 15
Helsinki 14
Tashkent 14
Princeton 13
Boston 12
Montreal 12
San Francisco 12
Tokyo 12
Brasília 11
London 11
Paris 11
San José 11
Belo Horizonte 10
Charlotte 10
Kuala Lumpur 10
Queens 10
Figino 9
Guayaquil 9
Manchester 9
Miami 9
Nairobi 9
Naples 9
Abbiategrasso 8
Ankara 8
Dublin 8
Fortaleza 8
Haiphong 8
Lissone 8
Philadelphia 8
Chandler 7
Houston 7
Indianapolis 7
Lawrence 7
Amsterdam 6
Baghdad 6
Brno 6
Buenos Aires 6
Campinas 6
Columbus 6
Dhaka 6
Erbil 6
Fairfield 6
Goiânia 6
Guarulhos 6
Hải Dương 6
Las Vegas 6
Pasadena 6
Piscataway 6
San Diego 6
Sydney 6
Abbeville 5
Austin 5
Benin City 5
Curitiba 5
Detroit 5
Istanbul 5
Lahore 5
Managua 5
Maracaibo 5
Memphis 5
Moscow 5
Poplar 5
Porto Alegre 5
Totale 4.922
Nome #
High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models 101
Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies 91
Molecular classification of hepatocellular carcinoma: The view from metabolic zonation 84
Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis 83
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: A proof-of-principle 82
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer 81
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations 81
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) 81
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast 80
PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer 80
Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma 79
Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations 78
A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer 77
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma 77
Cancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations 75
The Genomic Landscape of Male Breast Cancers 73
The Role of Chronic Liver Diseases in the Emergence and Recurrence of Hepatocellular Carcinoma: An Omics Perspective 72
Metaplastic breast carcinoma: more than a special type 72
Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer 71
Prognostic signatures in breast cancer: correlation does not imply causation 71
Alterations in Homologous Recombination Repair Genes in Prostate Cancer Brain Metastases 71
Genetic profiling using plasma-derived cell-free DNA in therapy-naive hepatocellular carcinoma patients: A pilot study 71
Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer 70
Breast cancer intratumor genetic heterogeneity: causes and implications 70
APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas 69
Hepatocellular Carcinoma Immune Microenvironment Analysis: A Comprehensive Assessment with Computational and Classical Pathology 69
Breast cancer intra-tumor heterogeneity 69
Genomic landscape of adenoid cystic carcinoma of the breast 69
The protein histidine phosphatase LHPP is a tumour suppressor 69
Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast 68
Genomic characterization of metastatic breast cancers 67
Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast 67
Combining two antibodies to define E-cadherin loss of expression in non-lobular breast carcinomas: when less is more 67
Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases 67
Structural analysis of the genome of breast cancer cell line ZR-75-30 identifies twelve expressed fusion genes 66
HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2(+) Breast Cancer 65
Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma 65
Standardizing Patient-Derived Organoid Generation Workflow to Avoid Microbial Contamination From Colorectal Cancer Tissues 65
Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors 64
Pregnancy at early age is associated with a reduction of progesterone-responsive cells and epithelial Wnt signaling in human breast tissue 63
Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook 63
SCIM: universal single-cell matching with unpaired feature sets 63
Genetic Alterations in Benign Breast Biopsies of Subsequent Breast Cancer Patients 62
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma 62
Hepatocellular Carcinoma Xenografts Established From Needle Biopsies Preserve the Characteristics of the Originating Tumors 62
Predictive performance of microarray gene signatures: impact of tumor heterogeneity and multiple mechanisms of drug resistance 62
The Genomic Landscape of Serrated Lesion of the Colorectum: Similarities and Differences With Tubular and Tubulovillous Adenomas 62
The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas 61
Progression from ductal carcinoma in situ to invasive breast cancer: revisited 61
Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo-Independent Regulation of Heat Shock Protein 70 Family Members 60
Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis 60
Stroma Transcriptomic and Proteomic Profile of Prostate Cancer Metastasis Xenograft Models Reveals Prognostic Value of Stroma Signatures 60
NGS-pipe: a flexible, easily extendable and highly configurable framework for NGS analysis 60
Massively parallel sequencing analysis of synchronous fibroepithelial lesions supports the concept of progression from fibroadenoma to phyllodes tumor 60
PIKing the type and pattern of PI3K pathway mutations in endometrioid endometrial carcinomas 60
Tandem duplication of chromosomal segments is common in ovarian and breast cancer genomes 60
Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes 60
Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens 60
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses 59
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib 59
ESR1 and endocrine therapy resistance: more than just mutations 59
Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression 59
Chromosomal instability determines taxane response 58
Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma 58
PipeIT: A Singularity Container for Molecular Diagnostic Somatic Variant Calling on the Ion Torrent Next-Generation Sequencing Platform 58
Patient-derived xenografts and organoids model therapy response in prostate cancer 58
Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing in ovarian cancer 58
The Role of Long Non-Coding RNAs in Hepatocarcinogenesis 57
PI3K pathway activation in high-grade ductal carcinoma in situ--implications for progression to invasive breast carcinoma 57
Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages 57
Phyllodes tumors with and without fibroadenoma-like areas display distinct genomic features and may evolve through distinct pathways 57
Diagnostic Targeted Sequencing Panel for Hepatocellular Carcinoma Genomic Screening 57
PipeIT2: A tumor-only somatic variant calling workflow for molecular diagnostic Ion Torrent sequencing data 57
Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases 57
Breast cancer genomics from microarrays to massively parallel sequencing: paradigms and new insights 57
Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer 56
Are acinic cell carcinomas of the breast and salivary glands distinct diseases? 56
Deciphering the clonal relationship between glandular and squamous components in adenosquamous carcinoma of the lung using whole exome sequencing 56
Infiltration by IL22-Producing T Cells Promotes Neutrophil Recruitment and Predicts Favorable Clinical Outcome in Human Colorectal Cancer 56
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support 56
Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer 56
Genomic profiling of histological special types of breast cancer 56
RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancers 56
Contralateral breast cancers: Independent cancers or metastases? 55
Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships 55
The role of tandem duplicator phenotype in tumour evolution in high-grade serous ovarian cancer 55
High-resolution genomic profiling of thyroid lesions uncovers preferential copy number gains affecting mitochondrial biogenesis loci in the oncocytic variants 55
Resolving quandaries: basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencing 54
HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models 54
The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment 53
Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas 53
Expression of RET is associated with Oestrogen receptor expression but lacks prognostic significance in breast cancer 53
Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology 53
Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations 53
Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer 52
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study 52
Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma 52
SF3B1 mutations constitute a novel therapeutic target in breast cancer 52
The Genomic Landscape of Mucinous Breast Cancer 52
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands 52
Totale 6.373
Categoria #
all - tutte 50.269
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.269


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202232 0 0 0 10 0 0 0 7 1 1 5 8
2022/202344 14 0 7 1 4 1 0 3 5 7 2 0
2023/2024767 1 4 5 2 0 339 54 56 14 10 112 170
2024/20251.506 27 5 8 22 11 173 88 96 320 429 160 167
2025/20264.599 629 384 170 386 123 250 1.210 217 182 341 340 367
2026/20271.728 232 322 786 388 0 0 0 0 0 0 0 0
Totale 8.733